STEMPOINT CAPITAL LP

Position in BIOA — BioAge Labs, Inc.

CIK 1952142 NEW YORK, NY

Position in BIOA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$11,376,831

+$5,453,773 QoQ

Shares Held

464,171

+37.1% QoQ

Ownership

1.01%

of shares outstanding

% of Portfolio

1.96%

of 13F equity value

Holder Rank

#20

of 151 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 87% Shared 0% None 13%

Healthcare · as of Jun 30, 2026

STEMPOINT CAPITAL LP holds $44,655,430 across 4 Drug Manufacturers - Specialty & Generic names. BIOA ranks #3 (25.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KNSA	Kiniksa Pharmaceuticals International, plc	209,234	$13,380,514
2	ALKS	Alkermes plc.	248,015	$12,995,986
3	BIOA	BioAge Labs, Inc. This page	464,171	$11,376,831
4	AMLX	Amylyx Pharmaceuticals, Inc.	384,304	$6,902,099

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,376,831	464,171	+37.1%	Shares	Sole	2026-08-14
2026-03-31	$5,923,058	338,654	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.